DocuSign price target raised to $85 from $80 at UBS

UBS raised the firm’s price target on DocuSign (DOCU) to $85 from $80 and keeps a Neutral rating on the shares. Stronger renewal activity drove a big billings beat in Q2, the analyst tells investors in a research note. The firm says the Q2 print “comes as a relief.”